{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "70518-4769",
      "generic_name": "Quetiapine",
      "labeler_name": "REMEDYREPACK INC.",
      "brand_name": "Quetiapine Extended Release",
      "brand_name_suffix": "Extended Release",
      "active_ingredients": [
        {
          "name": "QUETIAPINE FUMARATE",
          "strength": "300 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "70518-4769-0",
          "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (70518-4769-0)",
          "marketing_start_date": "20261008",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
      "spl_id": "5d5a2084-0ea1-0a83-e063-6294a90ab95d",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20261008",
      "product_id": "70518-4769_5d5a2084-0ea1-0a83-e063-6294a90ab95d",
      "application_number": "ANDA209635",
      "brand_name_base": "Quetiapine",
      "pharm_class": [
        "Atypical Antipsychotic [EPC]"
      ]
    }
  ]
}